The Ophthalmic Viscosurgical Devices market is expanding as ophthalmic surgery volumes increase and clinicians seek materials that provide reliable protection and controlled tissue manipulation during procedures. OVDs are widely used in cataract and other anterior-segment surgeries to maintain the surgical environment and support procedural precision.

The Ophthalmic Viscosurgical Devices Market size is expected to reach US$ 800.20 Million by 2034 from US$ 480.44 Million in 2025, registering a CAGR of 5.83% during 2026–2034. Ophthalmic viscosurgical devices (OVDs) are viscoelastic substances used during ophthalmic surgeries to maintain the shape and stability of the eye, protect delicate ocular tissues, and facilitate surgical manipulation. Increasing cataract surgery volumes, the aging population, advances in ophthalmic surgery, and growing adoption of minimally invasive procedures are supporting market expansion.

What is driving the market?

The increasing volume of cataract and other ophthalmic surgical procedures is a major factor driving the Ophthalmic Viscosurgical Devices Market.

Cataract surgery represents an important application for OVDs. These products help maintain the anterior chamber, protect the corneal endothelium, and facilitate the insertion and manipulation of intraocular lenses during surgery.

Get a Sample PDF- https://www.theinsightpartners.com/sample/TIPHE100001311

The global aging population is contributing to sustained demand for ophthalmic procedures. Age-related cataracts and other ocular conditions are increasingly creating demand for surgical interventions, supporting the use of specialized surgical products such as OVDs.

Technological developments in ophthalmic surgery are also influencing the market. Modern surgical techniques require OVD formulations with specific characteristics, including appropriate viscosity, elasticity, tissue protection, and ease of removal.

The growing adoption of advanced intraocular lenses and sophisticated cataract procedures is further supporting demand. As ophthalmic surgery becomes increasingly precise, surgeons require OVDs that can support different stages of complex procedures.

Which region leads?

North America represents a significant region in the Ophthalmic Viscosurgical Devices Market, supported by advanced ophthalmic healthcare infrastructure, high adoption of cataract surgery, and the presence of established medical-device and pharmaceutical companies.

The US is an important market because of its large ophthalmology sector and extensive network of hospitals, ambulatory surgical centers, and specialized eye-care facilities. Increasing demand for cataract and refractive procedures supports the use of OVD products.

Europe also represents an important market, supported by an aging population, established healthcare systems, and broad availability of ophthalmic surgical services. Technological developments in cataract surgery contribute to regional market opportunities.

Asia Pacific is expected to provide substantial growth opportunities as access to ophthalmic care improves and the number of cataract procedures increases. Expanding healthcare infrastructure, growing awareness of eye health, and rising healthcare expenditure are supporting market development.

Latin America and the Middle East and Africa also offer opportunities as governments, healthcare organizations, and private providers expand access to ophthalmic surgical services.

Which segment leads?

Cataract surgery represents a core application of the Ophthalmic Viscosurgical Devices Market because OVDs are routinely used to protect ocular tissues and facilitate surgical procedures.

The market can be segmented based on product type, application, end user, and geography. OVDs are commonly categorized according to their rheological characteristics and clinical functions, including cohesive and dispersive formulations.

Cohesive OVDs are valued for their ability to maintain space within the eye and facilitate surgical manipulation, while dispersive OVDs are used primarily for tissue protection. Some formulations combine characteristics of both categories to support multiple surgical requirements.

Cataract surgery remains a major application area, while OVDs may also be used in glaucoma, corneal, vitreoretinal, and other ophthalmic procedures.

Hospitals, ophthalmic clinics, and ambulatory surgical centers represent important end users. The increasing shift toward outpatient ophthalmic surgery is creating additional demand for efficient and reliable surgical products.

Which companies are prominent?

Leading companies are focusing on formulation development, tissue-protection performance, product portfolios, and ophthalmic surgical applications to strengthen their positions in the Ophthalmic Viscosurgical Devices Market.

• Abbott Medical Optics, Inc.
• Carl-Zeiss AG
• Novartis International AG
• Johnson & Johnson Vision Care, Inc.
• F. Hoffmann-La Roche Ltd.
• Pfizer, Inc.
• Allergan, Inc.
• Hyaltech Ltd.
• Valeant Pharmaceuticals International, Inc. (Bausch + Lomb, Inc.)
• CIMA Technology, Inc.
• Rayner

Competition is influenced by formulation characteristics, product safety, tissue-protection capabilities, ease of use, regulatory compliance, and compatibility with different ophthalmic procedures. Manufacturers are developing OVD formulations designed to address specific surgical requirements and improve handling during procedures.

Companies are also focusing on portfolio expansion, research and development, strategic partnerships, and geographic market expansion. Product development is increasingly centered on improving surgical performance while supporting efficient ophthalmic workflows.

What is changing in 2026?

In 2026, the Ophthalmic Viscosurgical Devices Market is increasingly moving toward specialized formulations, improved tissue protection, procedure-specific products, and more efficient ophthalmic surgical workflows.

Formulation innovation remains an important area of development. Manufacturers are working to optimize viscosity, elasticity, cohesion, dispersion, and removal characteristics to meet different surgical requirements.

The increasing use of advanced cataract surgery techniques is also influencing OVD development. Surgeons require products that can provide appropriate chamber maintenance and tissue protection throughout different stages of the procedure.

Combination formulations are gaining attention because they can provide multiple functional characteristics within a single product. These formulations may support both space maintenance and protection of sensitive ocular tissues.

The continued expansion of outpatient ophthalmic surgery is also affecting product requirements. Efficient handling, predictable performance, and convenient delivery formats can support faster and more standardized surgical workflows.

What are the major investment opportunities?

Major investment opportunities are emerging in advanced OVD formulations, procedure-specific products, tissue-protective technologies, and ophthalmic surgical solutions for growing cataract-care demand.

Advanced formulation development represents an important opportunity as surgeons seek OVDs with optimized rheological and protective properties. Products designed for specific surgical stages can address increasingly specialized clinical requirements.

The expanding cataract surgery market provides another important opportunity. Rising demand for cataract treatment, particularly among aging populations, creates sustained demand for OVDs used during lens-removal and intraocular-lens implantation procedures.

Combination OVD formulations also offer opportunities for product differentiation. Technologies that combine effective space maintenance, tissue protection, and convenient removal can support more efficient surgical workflows.

Emerging markets provide additional opportunities as ophthalmic infrastructure expands and access to cataract surgery improves. Increased availability of specialized eye-care facilities can broaden the adoption of advanced ophthalmic surgical products.

Related Reports @

Eye Anatomical Model Market Research Report by Size Share Analysis 2034

Ophthalmic Refractometer Market Size, Share & Demand by 2034

About Us –

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Us:
Contact Person: Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in : Korean German Japanese French Chinese Italian Spanish